Inspire Medical Systems, Inc. Operating Income
Inspire Medical Systems, Inc. (INSP) reported Operating Income of -$514.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-03
- Inspire Medical Systems, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$514.00K.
- Inspire Medical Systems, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$1.12M.
- Inspire Medical Systems, Inc. operating income (loss) for the quarter ending 2025-12-31 was $46.11M, a 44.62% increase year-over-year.
- Inspire Medical Systems, Inc. operating income (loss) for the quarter ending 2025-09-30 was $9.64M, a 32.64% decline year-over-year.
- Inspire Medical Systems, Inc. operating income (loss) for fiscal 2025 was $50.95M, a 41.21% increase from fiscal 2024.
- Inspire Medical Systems, Inc. operating income (loss) for fiscal 2024 was $36.08M.
- Inspire Medical Systems, Inc. operating income (loss) for fiscal 2023 was -$40.27M.
- Inspire Medical Systems, Inc. operating income (loss) for fiscal 2022 was -$47.59M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$514.00K 10-Q · filed 2026-08-03 | -$1.63M 10-Q · filed 2026-08-03 | $44.48M derived: sum of 3 quarters · filed 2026-08-03 | $54.12M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$1.12M 10-Q · filed 2026-05-04 | $44.99M derived: sum of 2 quarters · filed 2026-05-04 | $54.64M derived: sum of 3 quarters · filed 2026-05-04 | $51.32M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $46.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $55.76M derived: sum of 2 quarters · filed 2026-02-13 | $52.44M derived: sum of 3 quarters · filed 2026-08-03 | $50.95M 10-K · filed 2026-02-13 |
| 2025-09-30 | $9.64M 10-Q · filed 2025-11-03 | $6.33M derived: sum of 2 quarters · filed 2026-08-03 | $4.84M 10-Q · filed 2025-11-03 | $36.73M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$3.32M 10-Q · filed 2026-08-03 | -$4.80M 10-Q · filed 2026-08-03 | $27.08M derived: sum of 3 quarters · filed 2026-08-03 | $41.40M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$1.49M 10-Q · filed 2026-05-04 | $30.40M derived: sum of 2 quarters · filed 2026-05-04 | $44.72M derived: sum of 3 quarters · filed 2026-05-04 | $49.82M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $31.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $46.20M derived: sum of 2 quarters · filed 2026-02-13 | $51.30M derived: sum of 3 quarters · filed 2026-02-13 | $36.08M 10-K · filed 2026-02-13 |
| 2024-09-30 | $14.32M 10-Q · filed 2025-11-03 | $19.42M derived: sum of 2 quarters · filed 2025-11-03 | $4.20M 10-Q · filed 2025-11-03 | $13.50M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $5.10M 10-Q · filed 2025-08-04 | -$10.12M 10-Q · filed 2025-08-04 | -$822.00K derived: sum of 3 quarters · filed 2026-02-13 | -$14.29M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$15.22M 10-Q · filed 2025-05-05 | -$5.92M derived: sum of 2 quarters · filed 2026-02-13 | -$19.39M derived: sum of 3 quarters · filed 2026-02-13 | -$35.99M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$4.17M derived: sum of 2 quarters · filed 2026-02-13 | -$20.77M derived: sum of 3 quarters · filed 2026-02-13 | -$40.27M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$13.47M 10-Q · filed 2024-11-04 | -$30.07M derived: sum of 2 quarters · filed 2024-11-04 | -$49.57M 10-Q · filed 2024-11-04 | -$49.90M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | -$16.60M 10-Q · filed 2024-08-06 | -$36.10M 10-Q · filed 2024-08-06 | -$36.43M derived: sum of 3 quarters · filed 2025-02-10 | -$53.63M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | -$19.50M 10-Q · filed 2024-05-07 | -$19.83M derived: sum of 2 quarters · filed 2025-02-10 | -$37.03M derived: sum of 3 quarters · filed 2025-02-10 | -$51.03M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | -$335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$17.53M derived: sum of 2 quarters · filed 2025-02-10 | -$31.54M derived: sum of 3 quarters · filed 2025-02-10 | -$47.59M 10-K · filed 2025-02-10 |
| 2022-09-30 | -$17.19M 10-Q · filed 2023-11-07 | -$31.20M derived: sum of 2 quarters · filed 2023-11-07 | -$47.26M 10-Q · filed 2023-11-07 | -$49.08M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | -$14.01M 10-Q · filed 2023-08-01 | -$30.06M 10-Q · filed 2023-08-01 | -$31.88M derived: sum of 3 quarters · filed 2024-02-09 | -$41.68M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | -$16.06M 10-Q · filed 2023-05-02 | -$17.88M derived: sum of 2 quarters · filed 2024-02-09 | -$27.67M derived: sum of 3 quarters · filed 2024-02-09 | -$40.22M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | -$11.62M derived: sum of 2 quarters · filed 2024-02-09 | -$24.16M derived: sum of 3 quarters · filed 2024-02-09 | -$39.85M 10-K · filed 2024-02-09 |
| 2021-09-30 | -$9.80M 10-Q · filed 2022-11-01 | -$22.34M derived: sum of 2 quarters · filed 2022-11-01 | -$38.03M 10-Q · filed 2022-11-01 | -$45.09M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | -$12.54M 10-Q · filed 2022-08-02 | -$28.23M 10-Q · filed 2022-08-02 | -$35.30M derived: sum of 3 quarters · filed 2023-02-10 | -$45.19M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | -$15.69M 10-Q · filed 2022-05-03 | -$22.75M derived: sum of 2 quarters · filed 2023-02-10 | -$32.64M derived: sum of 3 quarters · filed 2023-02-10 | -$55.46M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | -$7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$16.95M derived: sum of 2 quarters · filed 2023-02-10 | -$39.77M derived: sum of 3 quarters · filed 2023-02-10 | -$56.21M 10-K · filed 2023-02-10 |
| 2020-09-30 | -$9.89M 10-Q · filed 2021-11-02 | -$32.71M derived: sum of 2 quarters · filed 2021-11-02 | -$49.15M 10-Q · filed 2021-11-02 | -$58.44M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$22.81M 10-Q · filed 2021-08-03 | -$39.25M 10-Q · filed 2021-08-03 | -$48.55M derived: sum of 3 quarters · filed 2022-02-15 | -$57.20M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$16.44M 10-Q · filed 2021-05-04 | -$25.73M derived: sum of 2 quarters · filed 2022-02-15 | -$34.38M derived: sum of 3 quarters · filed 2022-02-15 | -$42.56M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | -$9.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$17.94M derived: sum of 2 quarters · filed 2022-02-15 | -$26.12M derived: sum of 3 quarters · filed 2022-02-15 | -$34.90M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$8.65M 10-Q · filed 2020-11-02 | -$16.83M derived: sum of 2 quarters · filed 2020-11-02 | -$25.60M 10-Q · filed 2020-11-02 | -$30.50M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$8.18M 10-Q · filed 2020-08-04 | -$16.95M 10-Q · filed 2020-08-04 | -$21.85M derived: sum of 3 quarters · filed 2021-02-24 | -$26.50M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$8.78M 10-Q · filed 2020-05-05 | -$13.67M derived: sum of 2 quarters · filed 2021-02-24 | -$18.32M derived: sum of 3 quarters · filed 2021-02-24 | -$23.96M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$9.55M derived: sum of 2 quarters · filed 2021-02-24 | -$15.18M derived: sum of 3 quarters · filed 2021-02-24 | -$20.38M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$4.65M 10-Q · filed 2019-11-05 | -$10.29M derived: sum of 2 quarters · filed 2019-11-05 | -$15.48M 10-Q · filed 2019-11-05 | -$19.33M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$5.64M 10-Q · filed 2019-08-06 | -$10.83M 10-Q · filed 2019-08-06 | -$14.68M derived: sum of 3 quarters · filed 2020-02-25 | -$18.33M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$5.20M 10-Q · filed 2019-05-07 | -$9.04M derived: sum of 2 quarters · filed 2020-02-25 | -$12.69M derived: sum of 3 quarters · filed 2020-02-25 | -$17.07M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$7.50M derived: sum of 2 quarters · filed 2020-02-25 | -$11.88M derived: sum of 3 quarters · filed 2020-02-25 | -$16.00M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$3.65M 10-Q · filed 2018-11-06 | -$8.03M derived: sum of 2 quarters · filed 2018-11-06 | -$12.16M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$4.38M 10-Q · filed 2018-08-07 | -$8.51M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$4.12M 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | -$17.25M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |